Agile Therapeutics Inc (AGRX)
0.384
-0.02
(-5.14%)
USD |
OTCM |
May 03, 16:00
Agile Therapeutics Debt to Equity Ratio: -0.1045 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.1045 |
| September 30, 2023 | -0.1586 |
| June 30, 2023 | -0.1703 |
| March 31, 2023 | -0.1598 |
| December 31, 2022 | -0.2572 |
| September 30, 2022 | 0.2105 |
| June 30, 2022 | 3.694 |
| Date | Value |
|---|---|
| March 31, 2022 | 4.467 |
| December 31, 2021 | 4.300 |
| September 30, 2021 | 1.539 |
| June 30, 2021 | 0.6516 |
| March 31, 2021 | 0.4461 |
| December 31, 2020 | 0.3321 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.2572
Minimum
Dec 2022
4.467
Maximum
Mar 2022
1.138
Average
0.3321
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Altimmune Inc | 0.00 |
| iBio Inc | -- |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.26M |
| Total Liabilities (Quarterly) | 26.57M |
| Shareholders Equity (Quarterly) | -16.32M |
| Current Ratio | 0.4587 |
| Net Debt Paydown Yield | -1.34% |